Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 56, Issue 2, 2003, Pages 261-270

  Bussemer, T ^a   Peppas, N A ^b,c   Bodmeier, R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b The University of Texas at Austin   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Croscarmellose sodium; Hydroxypropyl cellulose; Pulsatile release; Swelling energy; Swelling force

Indexed keywords

CITRIC ACID TRIBUTYL ESTER; CITRIC ACID TRIETHYL ESTER; CROSCARMELLOSE SODIUM; CROSPOVIDONE; ETHYL CELLULOSE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; PHARMACOAT; POLYMER; POVIDONE; STARCH GLYCOLATE SODIUM; WATER;

ACIDITY; ARTICLE; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; EVALUATION; EXCIPIENT COMPATIBILITY; HYDRATION; IONIC STRENGTH; LINEAR SYSTEM; PHARMACEUTICAL ENGINEERING; PULSATILE DRUG RELEASE; SIMULATION;

EID: 0041334191     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(03)00070-5     Document Type: Article

References (29)

1. Bussemer T., Otto I., Bodmeier R. Pulsatile drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 18:(5):2001;433-458.
2. Lemmer B. Chronopharmacokinetics: implications for drug treatment. J. Pharm. Pharmacol. 51:1999;887-890.
3. Ritschel W.A., Forusz H. Chronopharmacology: a review of drugs studies. Methods Find. Exp. Clin. Pharmacol. 16:(1):1994;57-75.
4. Peppas N.A. Fundamentals on pH- and temperature-sensitive delivery systems. Pulsatile Drug Delivery. 1993;Wissenschaftliche Verlagsgesellschaft, Stuttgart. pp. 41-56.
5. R.W. Baker, Controlled release delivery system by an osmotic bursting mechanism. US Patent 3,952,741, 1976.
6. Ueda S., Hata T., Yamaguchi H., Kotani M., Ueda Y. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J. Drug Target. 2:1994;35-44.
7. Schultz P., Kleinebudde P.A. New multiparticulate delayed release system. Part I: dissolution properties and release mechanism. J. Control. Release. 47:1997;181-189.
8. Morita R., Honda R., Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design of SCRS and its release controlling factor. J. Control. Release. 63:2000;279-304.
9. Caramella C., Colombo P., Bettinetti G., Giordano F., Conte U., Manna A.L. Swelling properties of disintegrants. Acta Pharm. Technol. 30:(2):1984;132-139.
10. Wan L.S.C., Prasad K.P.P. Comparison of the swelling characteristics of tablet disintegrations at the microscopic level. Acta Pharm. Technol. 36:1990;20-23.
11. Gissinger D., Stamm A. A comparative evaluation of the properties of some tablet disintegrants. Drug Dev. Ind. Pharm. 6:(5):1980;511-536.
12. Gissinger D., Stamm A. A comparative study of cross-linked carboxymethylcellulose as tablet disintegrant. Pharm. Ind. 42:(2):1980;189-192.
13. Bell C.L., Peppas N.A. Measurement of the swelling force in ionic polymer networks. III. Swelling force of interpolymer complexes. J. Control. Release. 37:1995;277-280.
14. Bell C.L., Peppas N.A. An apparatus to measure polymer swelling under load. Int. J. Pharm. 134:1996;167-168.
15. Ende M.T.A., Bell C.L., Peppas N.A., Massimo G., Colombo P. Measurement of the swelling force in ionic polymeric network: II. Swelling force and disintegration of controlled release dosage formulations using ph-sensitive components. Int. J. Pharm. 120:1995;33-40.
16. Khare A.R., Peppas N.A., Massimo G., Colombo P. Measurement of the swelling force in ionic polymeric networks. I. Effect of pH and ionic content. J. Control. Release. 22:1992;239-244.
17. Shah U., Augsburger L. Evaluation of the functional equivalence of crospovidone NF from different sources. I. Physical characterization. Pharm. Dev. Technol. 6:(1):2001;39-51.
18. Colombo P., Conte U., Caramella C., Manna A.L. Force de delitement des comprimes. Farmaco [Prat.]. 35:(8):1980;391-402.
19. List P.H., Muazzam U.A. Swelling - the force that disintegrates. Drugs Made Germ. 22:(4):1979;161-170.
20. Massimo G., Catellani P.L., Santi P., Bettini R., Vaona G., Bonfanti A., Maggi L., Colombo P. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics. Pharm. Dev. Technol. 5:(2):2000;163-169.
21. Caramella C., Ferrari F., Ronchi M., Gazzaniga A., Conte U., Manna A.L. Relationships between water uptake and disintegration force in tablets of differing solubihity. Congres Int. Technol. Pharm. 3:1989;256-265.
22. Caramella C., Ferrari F., Bonferoni M.C., Ronchi M. Disintegrants in solid dosage forms. Drug Dev. Ind. Pharm. 16:(17):1990;2561-2577.
23. Catellani P.L., Predella P., Bellotti A., Colombo P. Tablet water uptake and disintegration force measurements. Int. J. Pharm. 51:1989;63-66.
24. Botzoloakis J., Augsburger L. Disintegrating agents in hard gelatin capsules. Part I: mechanism of action. Drug Dev. Ind. Pharm. 14:(1):1988;29-41.
25. Botzoloakis S., Augsburger L. Disintegrating agents in hard gelatin capsules. Part II: swelling efficiency. Drug Dev. Ind. Pharm. 14:(9):1988;1235-1248.
26. Colombo P., Conte U., Caramella C., Geddo M., Manna A.L. Disintegrating force as a new formulation parameter. J. Pharm. Sci. 73:(5):1984;701-705.
27. B.K. Low, H.N.E. Stevens, A.B. Mullen, PEG granulation prevents bursting of coated pellets containing disintegrants. British Pharmaceutical Conference Abstract Book 99 (2001).
28. Low B.K.K., Mullen A.B., Stevens H.N. Inhibition of rupture of pellets containing disintegrant and peg. AAPS Pharm Sci. 3:(Suppl 3):2001;W4166.
29. Peppas N.A., Colombo P. Development of disintegration forces during water penetration in porous pharmaceutical systems. J. Control. Release. 10:1989;245-250.